RSV Bronchiolitis – A Complete Patient‑Friendly Guide
Overview
Respiratory syncytial virus (RSV) bronchiolitis is an acute inflammation of the small airways (bronchioles) caused primarily by infection with RSV. It typically presents as a lower‑respiratory‑tract infection in infants and young children, leading to wheezing, coughing, and difficulty breathing.
Who it affects
- Infants < 12 months old, especially those < 6 months.
- Premature babies and those with chronic lung disease (e.g., bronchopulmonary dysplasia).
- Children with congenital heart disease or weakened immune systems.
- Older adults and immunocompromised adults can develop RSV bronchiolitis, though it is less common.
Prevalence
- RSV is the leading cause of bronchiolitis and pneumonia in children < 1 year old worldwide.
- In the United States, CDC estimates ~57,000 hospitalizations and 100–300 deaths annually among children < 5 years.
- Seasonality: peaks in late fall through early spring (November–March in the Northern Hemisphere).
Symptoms
Symptoms usually appear 4–6 days after exposure and progress over 2–3 days.
Early (Upper‑Respiratory) Signs
- Runny nose – watery, sometimes worsening to clear or yellow.
- Sore throat – may cause mild discomfort when feeding.
- Low‑grade fever – typically 37.5–38.5 °C (99.5–101.3 °F).
- Decreased appetite – infants may feed less or be irritable.
Progressive Lower‑Respiratory Signs (Bronchiolitis)
- Rapid breathing (tachypnea) – >60 breaths/min in infants, >40 in toddlers.
- Wheezing or whistling sound on exhalation.
- Chest retractions – skin pulls in between ribs (intercostal) or under the ribs (subcostal) as the child works harder to breathe.
- Cough – usually dry, may become productive.
- Fever spikes – up to 40 °C (104 °F) in severe cases.
- Fatigue or lethargy – child may be unusually sleepy.
- Grunting – a sound made on exhalation as the airway narrows.
Signs in High‑Risk Infants
- Apnea (brief pauses in breathing) – more common in preemies.
- Dehydration – dry lips, no tears, sunken fontanelle.
- Ongoing vomiting or poor weight gain.
Causes and Risk Factors
RSV is a single‑stranded RNA virus belonging to the Paramyxoviridae family. It spreads via respiratory droplets, direct contact with contaminated surfaces, and fomites.
Primary Cause
- Inhalation of RSV particles that infect the ciliated epithelium of the nasopharynx and then spread down to the bronchioles.
Risk Factors
- Age: < 12 months, with the highest risk in the first 3 months.
- Prematurity: < 37 weeks gestation; especially < 32 weeks.
- Chronic lung disease: bronchopulmonary dysplasia, cystic fibrosis.
- Congenital heart disease: especially cyanotic lesions.
- Immune compromise: chemotherapy, HIV, primary immunodeficiency.
- Environmental: exposure to tobacco smoke, crowded daycare, siblings in school.
- Seasonality: winter months increase exposure to circulating virus.
Diagnosis
Diagnosis is primarily clinical, supported by laboratory testing when the result will change management.
Clinical Evaluation
- History of rapid onset of cough, wheeze, and fever during RSV season.
- Physical exam showing tachypnea, retractions, and diffuse wheezing.
- Assessment of hydration status and oxygen saturation (pulse oximetry).
Laboratory & Imaging Tests
- Rapid antigen detection test (RADT): nasopharyngeal swab gives results within 15–30 minutes; sensitivity ~70‑80 %.
- Reverse‑transcriptase polymerase chain reaction (RT‑PCR): more sensitive (>95 %) and can detect co‑infections.
- Complete blood count (CBC): may show mild leukocytosis or lymphocytosis.
- Chest radiograph: typically not required; if performed, may show hyperinflation and peribronchial thickening, but no lobar consolidation (helps rule out bacterial pneumonia).
Treatment Options
There is no specific antiviral cure for routine RSV bronchiolitis. Management focuses on supportive care and, in selected high‑risk patients, targeted therapies.
Supportive Care (mainstay)
- Hydration: Encourage frequent, small feeds; consider nasogastric or IV fluids if oral intake is insufficient.
- Oxygen supplementation: Nasal cannula or high‑flow nasal cannula (HFNC) to maintain SpO₂ ≥ 92 % (≥ 94 % in infants with cardiac disease).
- Airway clearance: Gentle suctioning of nasal secretions; chest physiotherapy not routinely recommended.
- Fever control: Acetaminophen (paracetamol) 10–15 mg/kg per dose every 4‑6 hrs, max 5 doses/24 hrs.
Medications
- Bronchodilators (e.g., albuterol): Generally not beneficial; may be trialed in wheezing infants with a documented response.
- Corticosteroids: Not routinely indicated; may be used for underlying asthma.
- Ribavirin (inhaled): Reserved for severely immunocompromised patients or those with congenital heart disease; expensive and requires specialized equipment.
- Palivizumab (monoclonal antibody): Not a treatment but prophylaxis for high‑risk infants (see Prevention).
Procedures for Severe Disease
- Continuous Positive Airway Pressure (CPAP) or BiPAP: Helps maintain airway patency in moderate‑to‑severe respiratory distress.
- Mechanical ventilation: Indicated for respiratory failure or apnea unresponsive to non‑invasive support.
- Extracorporeal Membrane Oxygenation (ECMO): Rare, used in refractory cases.
Home Care Recommendations
- Maintain a humidified environment (cool‑mist humidifier) to ease breathing.
- Keep the child upright during feeds to reduce gagging.
- Monitor temperature and hydration closely; use oral rehydration solutions if needed.
Living with RSV Bronchiolitis
Even after the acute episode resolves, many families wonder how to support recovery and prevent future episodes.
Daily Management Tips
- Frequent feedings: Offer small amounts every 2–3 hours; consider breast‑milk or formula as tolerated.
- Hydration cues: Watch for moist mouth, wet diapers (≥ 6 per day), and normal tears.
- Monitor breathing: Count breaths per minute; note any new retractions, flaring, or wheeze.
- Sleep positioning: Place infant on back; use a slightly elevated head‑of‑bed (no pillows) to improve airway drainage.
- Environmental control: Keep indoor air free of smoke, strong fragrances, and excessive dust.
- Follow‑up: Schedule pediatric visits 48–72 hours after discharge to ensure improvement.
Long‑Term Outlook
- Most children recover fully within 1–2 weeks.
- Severe bronchiolitis in infancy is associated with a higher risk of recurrent wheeze and asthma later in childhood (≈ 30‑40 %); early control of environmental triggers can mitigate this risk.
Prevention
Preventing RSV infection is especially important for high‑risk infants.
General Preventive Measures
- Hand hygiene: Wash hands with soap and water for ≥ 20 seconds; alcohol‑based sanitizers are acceptable when hands are not visibly soiled.
- Avoid exposure: Keep sick family members away from infants; limit visits to crowded places during RSV season.
- Clean surfaces: Disinfect toys, doorknobs, and countertops daily with EPA‑registered disinfectants.
- No smoking: Eliminate second‑hand smoke exposure entirely.
High‑Risk Prophylaxis
- Palivizumab (Synagis): Monthly intramuscular injections during RSV season for:
- Premature infants (< 29 weeks gestation) up to 12 months corrected age.
- Infants < 12 months with chronic lung disease requiring oxygen or medications.
- Infants < 12 months with hemodynamically significant congenital heart disease.
Clinical trials show a 55‑80 % reduction in RSV‑related hospitalization (NIH, 2022).
Complications
Most cases are self‑limited, but complications can arise, particularly in vulnerable groups.
- Acute respiratory failure: Requires ventilatory support.
- Apnea: Common in preterm infants; may need monitoring and respiratory support.
- Secondary bacterial pneumonia: Suspect if fever persists > 5 days or sputum changes.
- Dehydration: From poor oral intake; can lead to electrolyte imbalances.
- Chronic lung disease: Prolonged wheezing or development of asthma.
- Cardiac stress: In children with underlying heart disease, RSV can precipitate heart failure.
When to Seek Emergency Care
Call 911 or go to the nearest emergency department immediately if your child shows any of the following:
- Breathing rate > 60 breaths/min (infants) or > 40 breaths/min (toddlers) and looks distressed.
- Noticeable chest retractions, grunting, or a “skin‑tight” appearance.
- Blue or gray coloration around lips, fingertips, or face (cyanosis).
- Persistent high fever > 40 °C (104 °F) or fever lasting > 3 days.
- Signs of severe dehydration: no tears when crying, dry mouth, sunken fontanel, or < 6 wet diapers in 24 hrs.
- Apnea episodes (pauses in breathing) or abnormal sleepiness/unresponsiveness.
- Vomiting that prevents any oral intake for > 12 hours.
Early emergency evaluation can prevent progression to respiratory failure.
References:
- Mayo Clinic. Respiratory syncytial virus (RSV) – Symptoms & causes. Accessed June 2024.
- Centers for Disease Control and Prevention. RSV and High‑Risk Infants. Updated 2023.
- National Institutes of Health. RSV – NHLBI. 2022 review.
- Cleveland Clinic. Respiratory Syncytial Virus (RSV). 2023.
- World Health Organization. RSV Fact Sheet. 2022.
- American Academy of Pediatrics. Guidelines for Management of Bronchiolitis (2024 Update).